These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21487942)

  • 41. Clinical spectrum of urine cultures positive for ESBL-producing Escherichia coli in hospitalized patients and impact on antibiotic use.
    Lepeule R; Leflon-Guibout V; Vanjak D; Zahar JR; Lafaurie M; Besson C; Lefort A;
    Med Mal Infect; 2014 Dec; 44(11-12):530-4. PubMed ID: 25311839
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). III. Secular changes in susceptibility].
    Kumamoto Y; Tsukamoto T; Matsukawa M; Kunishima Y; Hirose T; Shigeta S; Yamaguchi O; Ishibashi K; Suzutani T; Yoshida H; Imafuku Y; Murai M; Watanabe K; Kobayashi Y; Uchida H; Matsuda S; Sato S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Furuya N; Deguchi T; Ishihara S; Ooe H; Oka T; Kitamura M; Fukuhara Y; Kamidono S; Arakawa S; Kumon H; Monden K; Matsumoto T; Muratani T; Naito S; Egashira T; Konishi T; Kohno S; Hirakata Y; Kondo A; Matsuda J; Nakano M
    Jpn J Antibiot; 2006 Aug; 59(4):217-315. PubMed ID: 17111595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005-2014.
    Stapleton PJ; Lundon DJ; McWade R; Scanlon N; Hannan MM; O'Kelly F; Lynch M
    Ir J Med Sci; 2017 Aug; 186(3):733-741. PubMed ID: 28054236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prevalence and predictors of extended spectrum B-lactamase urinary tract infections among emergency department patients: A retrospective chart review.
    Bou Chebl R; Assaf M; Kattouf N; Abou Arbid S; Haidar S; Geha M; Makki M; Tamim H; Abou Dagher G
    Am J Emerg Med; 2021 Nov; 49():304-309. PubMed ID: 34182275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Resistant phenotypes of Escherichia coli strains responsible for urinary tract infection in the laboratory of the University Hospital Joseph Raseta Befelatanana, Antananarivo].
    Rakotovao-Ravahatra ZD; Randriatsarafara FM; Rasoanandrasana S; Raverohanta L; Rakotovao AL
    Pan Afr Med J; 2017; 26():166. PubMed ID: 28674559
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug susceptibility and treatment response of common urinary tract infection pathogens in children.
    Chen PC; Chang LY; Lu CY; Shao PL; Tsai IJ; Tsau YK; Lee PI; Chen JM; Hsueh PR; Huang LM
    J Microbiol Immunol Infect; 2014 Dec; 47(6):478-83. PubMed ID: 24064294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in kidney transplant patients.
    Pinheiro HS; Mituiassu AM; Carminatti M; Braga AM; Bastos MG
    Transplant Proc; 2010 Mar; 42(2):486-7. PubMed ID: 20304172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Refractory vertebral osteomyelitis due to CTX-M-14-producing Escherichia coli at ertapenem treatment in a patient with a coexisting urinary tract infection caused by the same pathogen.
    Lee CH; Su LH; Lin WC; Tang YF; Liu JW
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e183-6. PubMed ID: 19800278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Community-acquired febrile urinary tract infection caused by extended-spectrum beta-lactamase-producing bacteria in hospitalised infants.
    Hernández Marco R; Guillén Olmos E; Bretón-Martínez JR; Giner Pérez L; Casado Sánchez B; Fujkova J; Salamanca Campos M; Nogueira Coito JM
    Enferm Infecc Microbiol Clin; 2017 May; 35(5):287-292. PubMed ID: 26976379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of other antimicrobial drugs is associated with trimethoprim resistance in patients with urinary tract infections caused by E. coli.
    Mulder M; Verbon A; Lous J; Goessens W; Stricker BH
    Eur J Clin Microbiol Infect Dis; 2019 Dec; 38(12):2283-2290. PubMed ID: 31494829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibiotic resistance of Escherichia coli isolated from uncomplicated UTI in general practice patients over a 10-year period.
    van Driel AA; Notermans DW; Meima A; Mulder M; Donker GA; Stobberingh EE; Verbon A
    Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2151-2158. PubMed ID: 31440915
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between urinary tract infection categorization and pathogens' antimicrobial susceptibilities.
    Yamamichi F; Shigemura K; Matsumoto M; Nakano Y; Tanaka K; Arakawa S; Fujisawa M
    Urol Int; 2012; 88(2):198-208. PubMed ID: 22237308
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Retrospective review of ceftriaxone versus levofloxacin for treatment of E. coli urinary tract infections.
    Wang SS; Ratliff PD; Judd WR
    Int J Clin Pharm; 2018 Feb; 40(1):143-149. PubMed ID: 29147962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resistance trends and risk factors of extended spectrum β-lactamases in Escherichia coli infections in Aleppo, Syria.
    Al-Assil B; Mahfoud M; Hamzeh AR
    Am J Infect Control; 2013 Jul; 41(7):597-600. PubMed ID: 23337303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009-2010.
    Hoban DJ; Nicolle LE; Hawser S; Bouchillon S; Badal R
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):507-11. PubMed ID: 21767706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. First-Line Antimicrobial Resistance Patterns of Escherichia coli in Children With Urinary Tract Infection in Emergency Department and Primary Care Clinics.
    Ahmed MN; Vannoy D; Frederick A; Chang S; Lawler E
    Clin Pediatr (Phila); 2016 Jan; 55(1):19-28. PubMed ID: 26040907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of cefuroxime for women with community-onset acute pyelonephritis caused by cefuroxime-susceptible or -resistant Escherichia coli.
    Chang UI; Kim HW; Wie SH
    Korean J Intern Med; 2016 Jan; 31(1):145-55. PubMed ID: 26767868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Are beta-lactams related to higher morbidity and mortality in urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli?
    You JH; Kei HW; Lau WC; Wong KY; Marasinghe T; Lee N; Ip M
    J Hosp Infect; 2008 Feb; 68(2):181-3. PubMed ID: 18194826
    [No Abstract]   [Full Text] [Related]  

  • 60. Potential role of fosfomycin in the treatment of community-acquired lower urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Wilson DT; May DB
    Am J Ther; 2013; 20(6):685-90. PubMed ID: 21768870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.